Larimar Therapeutics, Inc. Liquidation Value
LRMR
Other
Cash & Equivalents
$85.41M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $85.41M
Total Obligations: -$68.86M
$16.55M
Per share: $0.20
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $85.41M
AR: $0
Total Obligations: -$68.86M
$16.55M
Per share: $0.20
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $85.41M
AR: $0
Inventory: $0
Total Obligations: -$68.86M
$16.55M
Per share: $0.20
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $16.55M | $0.20 |
| Liquid Liquidation Value | $16.55M | $0.20 |
| Operating Liquidation Value | $16.55M | $0.20 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $85.41M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $64.80M |
| Long-term Debt | N/A |
| Op. Lease Liability | $4.07M |
| Finance Lease | N/A |
| Shares Outstanding | 83.1M |
Explore all 119 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $85.41M | N/A | N/A | $5.22M | $64.80M | N/A | $4.07M | N/A |
| 2025-09-30 | $90.14M | N/A | N/A | $11.10M | $45.12M | N/A | $4.35M | N/A |
| 2025-06-30 | $20.59M | N/A | N/A | $4.17M | $26.65M | N/A | $4.61M | N/A |
| 2025-03-31 | $21.13M | N/A | N/A | $2.27M | $22.13M | N/A | $4.87M | N/A |
| 2024-12-31 | $33.22M | N/A | N/A | $2.42M | $24.36M | N/A | $5.12M | N/A |
| 2024-09-30 | $35.07M | N/A | N/A | $1.69M | $16.29M | N/A | $5.36M | N/A |
| 2024-06-30 | $32.31M | N/A | N/A | $2.92M | $21.16M | N/A | $5.59M | N/A |
| 2024-03-31 | $110.12M | N/A | N/A | $1.92M | $12.84M | N/A | $5.34M | N/A |
▼ Community Notes